# A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity

> **NCT06780449** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 400 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Cagrilintide
- **DRUG:** Semaglutide
- **DRUG:** Placebo cagrilintide
- **DRUG:** Placebo semaglutide

## Key facts

- **NCT ID:** NCT06780449
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-02-10
- **Primary completion:** 2028-08-28
- **Final completion:** 2028-10-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06780449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06780449, "A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06780449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*